» Articles » PMID: 24663384

Heart Failure with Preserved Ejection Fraction

Overview
Journal Pflugers Arch
Specialty Physiology
Date 2014 Mar 26
PMID 24663384
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

As part of this series devoted to heart failure (HF), we review the epidemiology, diagnosis, pathophysiology, and treatment of HF with preserved ejection fraction (HFpEF). Gaps in knowledge and needed future research are discussed.

Citing Articles

Progress of echocardiography in the evaluation of left atrial function in patients with heart failure with preserved ejection fraction: a narrative review.

Liang C, Yu D, Yu T, Li J, Xue L Quant Imaging Med Surg. 2024; 14(12):9667-9684.

PMID: 39698656 PMC: 11652033. DOI: 10.21037/qims-24-993.


ALPK2 prevents cardiac diastolic dysfunction in heart failure with preserved ejection fraction.

Yoshida T, Yoshida S, Inukai K, Kato K, Yura Y, Hattori T FASEB J. 2024; 38(22):e70192.

PMID: 39556326 PMC: 11599786. DOI: 10.1096/fj.202402103R.


Diastolic Dysfunction of the Left and Right Ventricles in Patients with Calcium Pyrophosphate Crystal Storage Disease and Osteoarthritis.

Eliseev M, Zhelyabina O, Kirillova I, Korsakova Y, Cheremushkina E Dokl Biochem Biophys. 2024; 517(1):148-155.

PMID: 38861149 DOI: 10.1134/S1607672924700881.


[Heart Failure With Preserved Ejection Fraction: A Problem Of Contemporary Cardiology].

Saldarriaga-Giraldo C, Ramirez-Ramos C, Gallego C, Castilla-Agudelo G, Aranzazu-Uribe M, Saldarriaga-Betancur S Arch Peru Cardiol Cir Cardiovasc. 2024; 1(2):85-93.

PMID: 38572331 PMC: 10986356. DOI: 10.47487/apcyccv.v1i2.53.


Post-translational modifications of proteins in cardiovascular diseases examined by proteomic approaches.

Stastna M FEBS J. 2024; 292(1):28-46.

PMID: 38440918 PMC: 11705224. DOI: 10.1111/febs.17108.


References
1.
Abudiab M, Redfield M, Melenovsky V, Olson T, Kass D, Johnson B . Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail. 2013; 15(7):776-85. PMC: 3857919. DOI: 10.1093/eurjhf/hft026. View

2.
Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, Greaser M . PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ Res. 2009; 105(7):631-8, 17 p following 638. PMC: 2764991. DOI: 10.1161/CIRCRESAHA.109.198465. View

3.
Kruger M, Linke W . Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension. J Muscle Res Cell Motil. 2006; 27(5-7):435-44. DOI: 10.1007/s10974-006-9090-5. View

4.
Andersen M, Ersboll M, Axelsson A, Gustafsson F, Hassager C, Kober L . Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial. Circulation. 2013; 127(11):1200-8. DOI: 10.1161/CIRCULATIONAHA.112.000056. View

5.
Mohammed S, Borlaug B, Roger V, Mirzoyev S, Rodeheffer R, Chirinos J . Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail. 2012; 5(6):710-9. PMC: 3767407. DOI: 10.1161/CIRCHEARTFAILURE.112.968594. View